Predicting PARP inhibitor sensitivity and resistance

por Bebb, D. Gwyn, Lees-Miller, Susan P.
Publicado 2012

Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and Caregivers

por Bebb, D. Gwyn, Murray, Cressida, Giannopoulou, Andromachi, Felip, Enriqueta
Publicado 2023

Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: associations with quality of life

por Stephenson, Lynette E, Bebb, D Gwyn, Reimer, Raylene A, Culos-Reed, S Nicole
Publicado 2009

ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib()

por Wang, Chen, Jette, Nicholas, Moussienko, Daniel, Bebb, D. Gwyn, Lees-Miller, Susan P.
Publicado 2017

The prevalence and prognostic significance of estrogen receptor beta expression in non-small cell lung cancer

por Enwere, Emeka K., Dean, Michelle L., Li, Haocheng, D’Silva, Adrijana, Bebb, D. Gwyn
Publicado 2020

Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors

por Gibson, Amanda J.W., Box, Adrian, Dean, Michelle L., Elegbede, Anifat A., Hao, Desiree, Sangha, Randeep, Bebb, D. Gwyn
Publicado 2021

A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada

por Elegbede, Anifat A., Gibson, Amanda J., Fung, Andrea S., Cheung, Winson Y., Dean, Michelle L., Bebb, D. Gwyn, Pabani, Aliyah
Publicado 2021

Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment

por Hao, Desirée, Sarfaraz, M. Omair, Farshidfar, Farshad, Bebb, D. Gwyn, Lee, Camelia Y., Card, Cynthia M., David, Marilyn, Weljie, Aalim M.
Publicado 2016

CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients

por Fung, Andrea S., Kopciuk, Karen, Dean, Michelle L., D’Silva, Adrijana, Otsuka, Shannon, Klimowicz, Alexander, Hao, Desiree, Morris, Don, Bebb, D. Gwyn
Publicado 2021

Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells

por Jette, Nicholas R., Radhamani, Suraj, Arthur, Greydon, Ye, Ruiqiong, Goutam, Siddhartha, Bolyos, Anthony, Petersen, Lars F., Bose, Pinaki, Bebb, D. Gwyn, Lees-Miller, Susan P.
Publicado 2019

Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells

por Jette, Nicholas R., Radhamani, Suraj, Arthur, Greydon, Ye, Ruiqiong, Goutam, Siddhartha, Bolyos, Anthony, Petersen, Lars F., Bose, Pinaki, Bebb, D. Gwyn, Lees-Miller, Susan P.
Publicado 2020

Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada

por O’Sullivan, Dylan E., Cheung, Winson Y., Syed, Iqra A., Moldaver, Daniel, Shanahan, Mary Kate, Bebb, D. Gwyn, Sit, Christina, Brenner, Darren R., Boyne, Devon J.
Publicado 2021

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors

por Meyers, Daniel E., Stukalin, Igor, Vallerand, Isabelle A., Lewinson, Ryan T., Suo, Aleksi, Dean, Michelle, North, Scott, Pabani, Aliyah, Cheng, Tina, Heng, Daniel Y.C., Bebb, D. Gwyn, Morris, Don G.
Publicado 2019

Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53

por Williamson, Chris T, Kubota, Eiji, Hamill, Jeffrey D, Klimowicz, Alexander, Ye, Ruiqiong, Muzik, Huong, Dean, Michelle, Tu, LiRen, Gilley, David, Magliocco, Anthony M, McKay, Bruce C, Bebb, D Gwyn, Lees-Miller, Susan P
Publicado 2012

Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC

por Petersen, Lars F., Klimowicz, Alexander C., Otsuka, Shannon, Elegbede, Anifat A., Petrillo, Stephanie K., Williamson, Tyler, Williamson, Chris T., Konno, Mie, Lees-Miller, Susan P., Hao, Desiree, Morris, Don, Magliocco, Anthony M., Bebb, D. Gwyn
Publicado 2017

Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Datab...

por Grosjean, Heidi A. I., Dolter, Samantha, Meyers, Daniel E., Ding, Philip Q., Stukalin, Igor, Goutam, Siddhartha, Kong, Shiying, Chu, Quincy, Heng, Daniel Y. C., Bebb, D. Gwyn, Morris, Don G., Cheung, Winson Y., Pabani, Aliyah
Publicado 2021

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults †

por Bebb, D. Gwyn, Banerji, Shantanu, Blais, Normand, Desmeules, Patrice, Gill, Sharlene, Grin, Andrea, Feilotter, Harriet, Hansen, Aaron R., Hyrcza, Martin, Krzyzanowska, Monika, Melosky, Barbara, Noujaim, Jonathan, Purgina, Bibiana, Ruether, Dean, Simmons, Christine E., Soulieres, Denis, Torlakovic, Emina Emilia, Tsao, Ming-Sound
Publicado 2021